C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/12 (2006.01) A61K 31/444 (2006.01) A61P 35/00 (2006.01) C07D 213/82 (2006.01)
Patent
CA 2696197
Objects of the present invention are the compounds of formula (I) their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above- mentioned compounds in the control or prevention of illnesses such as cancer.
La présente invention porte sur des composés représentés par la formule (I), sur leurs sels pharmaceutiquement acceptables, leurs formes énantiomères, leurs diastéréoisomères et leurs racémates, sur la préparation des composés mentionnés ci-dessus, sur des médicaments les contenant et sur leur fabrication, ainsi que sur l'utilisation des composés mentionnés ci-dessus dans la lutte contre ou la prévention des maladies telles que le cancer.
Georges Guy
Kaluza Klaus
Koerner Matthias
Reiff Ulrike
Scheiblich Stefan
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Pyridoneamide derivatives as focal adhesion kinase (fak)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridoneamide derivatives as focal adhesion kinase (fak)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridoneamide derivatives as focal adhesion kinase (fak)... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1383452